CIK 0001674416
- Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- Operating
- EIN
- 473173478
- Phone
- +1 617-315-4600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $4,881,673
- in 7 filings, $1.5M under 10b5-1 plans
Net −$4,881,673. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 60 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-19 | Novak Rodger President | Option exercise | +33,618 | $14.43 | $485K | 33,618 |
| 2019-11-19 | Novak Rodger President | Sale | −33,618 | $70.00 | $2.4M | 0 |
| 2019-11-19 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −33,618 | 236,382 | ||
| 2019-07-10 | Novak Rodger President | Sale | −50,000 | $50.00 | $2.5M | 848,007 |
| 2019-06-10 | Novak Rodger President | Sale | −50,000 | $45.00 | $2.3M | 898,007 |
| 2019-03-04 | Novak Rodger President | Sale | −64,115 | $40.24 | $2.6M | 960,419 |
| 2019-03-04 | Novak Rodger President | Sale | −8,912 | $41.29 | $368K | 951,507 |
| 2019-03-04 | Novak Rodger President | Sale | −3,500 | $42.03 | $147K | 948,007 |
| 2019-03-01 | Novak Rodger President | Sale | −8,693 | $40.01 | $348K | 1,024,534 |
| 2019-02-25 | Novak Rodger President | Sale | −14,780 | $40.00 | $591K | 1,033,227 |
| 2019-01-09 | Novak Rodger President | Sale | −82,690 | $35.01 | $2.9M | 1,048,007 |
| 2019-01-08 | Novak Rodger President | Sale | −17,310 | $35.09 | $607K | 1,130,697 |
| 2018-05-17 | Novak Rodger President | Option exercise | +35,240 | $1.81 | $64K | 1,183,247 |
| 2018-05-17 | Novak Rodger President | Option exercise | +39,760 | $14.00 | $557K | 1,223,007 |
| 2018-05-17 | Novak Rodger President | Sale | −75,000 | $60.00 | $4.5M | 1,148,007 |
| 2018-05-17 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −35,240 | 5,586 | ||
| 2018-05-17 | Novak Rodger President | Option exercise · Stock Option (Right to Buy) | −39,760 | 160,240 | ||
| 2017-09-05 | Novak Rodger Chief Executive Officer | Option exercise | +3,853 | $1.81 | $7K | 1,151,860 |
| 2017-09-05 | Novak Rodger Chief Executive Officer | Sale | −3,853 | $20.33 | $78K | 1,148,007 |
| 2017-09-05 | Novak Rodger Chief Executive Officer | Option exercise · Stock Options (Right to Buy) | −3,853 | 40,826 |
Page 3 of 4 · 67 trades